Ernexa Therapeutics (ERNAW) Prepaid Assets (2010 - 2026)
Ernexa Therapeutics (ERNAW) reported Prepaid Assets of $724000.0 for Q1 2026, up 428.47% on a YoY basis from $137000.0 in Q1 2025, and up 79.21% quarter-over-quarter from $404000.0 in Q4 2025.
Ernexa Therapeutics (ERNAW) Prepaid Assets (2010 - 2026) Analysis & Trends
Ernexa Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $724000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 428.47% year-over-year to $724000.0; the trailing twelve-month figure through Mar 2026 stood at $724000.0 (up 428.47% YoY), and the FY2025 full-year result was $404000.0, up 117.2% from the prior year.
- Prepaid Assets for Q1 2026 stood at $724000.0, up from $404000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.8 million in Q2 2022, with the low at $137000.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $771882.4 across 5 years, with a median of $704000.0 in 2023.
- Annual changes were most pronounced in 2024 — Prepaid Assets tumbled 88.37% — and 2026, when it jumped 428.47%.
- Ernexa Therapeutics' Prepaid Assets stood at $1.3 million in 2022, then climbed by 24.53% to $1.6 million in 2023, then plunged by 88.37% to $186000.0 in 2024, then jumped by 117.2% to $404000.0 in 2025, then jumped by 79.21% to $724000.0 in 2026.
- The last three Prepaid Assets figures came in at $724000.0 (Q1 2026), $404000.0 (Q4 2025), and $179000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ernexa Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 724,000.00 |
| Dec 31, 2025 | 404,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 323,000.00 |
| Mar 31, 2025 | 137,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 279,000.00 |
| Jun 30, 2024 | 769,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 704,000.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 471,000.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 1.82 Mn |
| Mar 31, 2022 | 800,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 1.75 Mn |